{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:30:51Z","timestamp":1775251851575,"version":"3.50.1"},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.2169\/internalmedicine.1698-18","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T18:30:37Z","timestamp":1539714637000},"page":"821-825","source":"Crossref","is-referenced-by-count":6,"title":["Hypophosphatemic Osteomalacia Associated with Adefovir-induced Fanconi Syndrome Initially Diagnosed as Diabetic Kidney Disease and Vitamin D Deficiency"],"prefix":"10.2169","volume":"58","author":[{"given":"Ryo","family":"Koda","sequence":"first","affiliation":[{"name":"Department of Nephrology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Tsuchida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Iino","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B. N Engl J Med 348: 800-807, 2003.","DOI":"10.1056\/NEJMoa021812"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Marcellin P, Chang TT, Lim SG, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 348: 808-816, 2003.","DOI":"10.1056\/NEJMoa020681"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tanaka M, Suzuki F, Seko Y, et al. Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B. J Gastroenterol 49: 470-480, 2014.","DOI":"10.1007\/s00535-013-0779-0"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shimizu M, Furusyo N, Ikezaki H, et al. Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B. World J Gastroenterol 21: 2116-2123, 2015.","DOI":"10.3748\/wjg.v21.i7.2116"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cihlar T, Ho ES, Lin DC, Mulato AS. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids 20: 641-648, 2001.","DOI":"10.1081\/NCN-100002341"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miller DS. Nucleoside phosphonate interactions with multiple organic anion transporters in renal proximal tubule. J Pharmacol Exp Ther 299: 567-574, 2001.","DOI":"10.1016\/S0022-3565(24)29264-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, D'agati VD. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol 32: 734-740, 2001.","DOI":"10.1053\/hupa.2001.25586"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Park S, Kim WI, Cho DH, et al. Adefovir-induced Fanconi syndrome associated with osteomalacia. Clin Mol Hepatol 24: 339-344, 2017 (Epub ahead of print).","DOI":"10.3350\/cmh.2017.0009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Jung YK, Yeon JE, Choi JH, et al. Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis b virus patient. Gut Liver 4: 389-393, 2010.","DOI":"10.5009\/gnl.2010.4.3.389"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Girgis CM, Wong T, Ngu MC, et al. Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol 45: 468-473, 2011.","DOI":"10.1097\/MCG.0b013e3181e12ed3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Law ST, Li KK, Ho YY. Acquired Fanconi syndrome associated with prolonged adefovir dipivoxil therapy in a chronic hepatitis B patient. Am J Ther 20: e713-e716, 2013.","DOI":"10.1097\/MJT.0b013e31820c4b20"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Law ST, Li KK, Ho YY. Nephrotoxicity, including acquired Fanconi's syndrome, caused by adefovir dipivoxil - is there a safe dose? J Clin Pharm Ther 37: 128-131, 2012.","DOI":"10.1111\/j.1365-2710.2011.01278.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tanaka M, Setoguchi T, Ishidou Y, et al. Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report. Diagn Pathol 7: 108, 2012.","DOI":"10.1186\/1746-1596-7-108"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shimohata H, Sakai S, Ogawa Y, Hirayama K, Kobayashi M. Osteomalacia due to Fanconi's syndrome and renal failure caused by long-term low-dose adefovir dipivoxil. Clin Exp Nephrol 17: 147-148, 2013.","DOI":"10.1007\/s10157-012-0762-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wu C, Zhang H, Qian Y, Wang L, Gu X, Dai Z. Hypophosphatemic osteomalacia and renal Fanconi syndrome induced by low-dose adefovir dipivoxil: a case report and literature review suggesting ethnic predisposition. J Clin Pharm Ther 38: 321-326, 2013.","DOI":"10.1111\/jcpt.12050"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Eguchi H, Tsuruta M, Tani J, Kuwahara R, Hiromatsu Y. Hypophosphatemic osteomalacia due to drug-induced Fanconi's syndrome associated with adefovir dipivoxil treatment for hepatitis B. Intern Med 53: 233-237, 2014.","DOI":"10.2169\/internalmedicine.53.1213"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Palermo A, Strollo R, Papalia R, et al. Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: a case report. Endocr Pract 20: e246-e249, 2014.","DOI":"10.4158\/EP14251.CR"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lee SSM, Quek TPL, Seow CJ, Leow MKS. Adefovir-induced Fanconi syndrome: diagnostic pearls and perils of late or missed diagnosis. CEN Case Rep 3: 183-187, 2014.","DOI":"10.1007\/s13730-014-0114-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lin J, Zhuo Y, Zhang D. Nephrolithiasis and osteomalacia associated with adefovir-induced Fanconi syndrome in a patient with hepatitis B. BMC Nephrol 18: 275, 2017.","DOI":"10.1186\/s12882-017-0693-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Li X, Shen M, Sun WJ, Huang ZX, An N, Zhang JJ. Misdiagnosis of bone metastasis cancer after using adefovir dipivoxi in a hepatitis B patient with Fanconi syndrome. Indian J Hematol Blood Transfus 32: 329-331, 2016.","DOI":"10.1007\/s12288-015-0501-x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wei WJ, Sun ZK, Shen CT, Qiu ZL, Luo QY. Adefovir-induced hypophosphatemic osteomalacia mimicking bone metastases from primary hepatocarcinoma. Clin Nucl Med 42: e405-e406, 2017.","DOI":"10.1097\/RLU.0000000000001756"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lin Y, Pan F, Wang Y, et al. Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: a study of 28 cases. Oncol Lett 13: 307-314, 2017.","DOI":"10.3892\/ol.2016.5393"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chen N, Zhang JB, Zhang Q, et al. Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series. BMC Pharmacol Toxicol 19: 23, 2018.","DOI":"10.1186\/s40360-018-0212-7"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jia HY, Ding F, Chen JY, et al. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B. World J Gastroenterol 21: 3657-3662, 2015.","DOI":"10.3748\/wjg.v21.i12.3657"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Takagi J, Morita H, Ito K, et al. Urinary \u03b2-2 microglobulin levels sensitively altered in an osteomalacia patient receiving add-on adefovir dipivoxil therapy for hepatitis B virus infection. Intern Med 55: 1599-1603, 2016.","DOI":"10.2169\/internalmedicine.55.6301"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Farnik H, Bojunga J, Berger A, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology 58: 1270-1276, 2013.","DOI":"10.1002\/hep.26488"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lee YS, Kim BK, Lee HJ, Dan J. Pathologic femoral neck fracture due to Fanconi syndrome induced by adefovir dipivoxil therapy for hepatitis B. Clin Orthop Surg 8: 232-236, 2016.","DOI":"10.4055\/cios.2016.8.2.232"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/6\/58_1698-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:20:18Z","timestamp":1775247618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/6\/58_1698-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1698-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]}}}